AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21122491 — intervention group
Group type: EXPERIMENTAL
Intervention: 4g enema administered daily (Group A, 15 pts)
Number of subjects: 45
Study 21122491 — intervention group
Group type: EXPERIMENTAL
Intervention: 4g enema administered every 2 days (Group B, 15 pts)
Number of subjects: 45
Study 21122491 — intervention group
Group type: EXPERIMENTAL
Intervention: 4g enema administered every 3 days (Group C, 15 pts)
Number of subjects: 45
Study 21122491 — intervention group
Group type: COMPARATOR
Intervention: Oral Mesalazine treatment alone (OT)
Number of subjects: 45
Study 18047869 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 38
Study 18047869 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 38
Study 18047869 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine (active placebo)
Number of subjects: 38
Study 18047869 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline vs Gabapentin
Number of subjects: 38
Study 18047869 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline vs Diphenhydramine
Number of subjects: 38
Study 18047869 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline, Gabapentin, Diphenhydramine
Number of subjects: 38
Study 16127749 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (1-8 microg/mL, 100 mL)
Number of subjects: 84
Study 16127749 — intervention group
Group type: COMPARATOR
Intervention: Capsaicin (3x400 microg i.g. for two weeks)
Number of subjects: 84
Study 12359649 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to dust or fumes
Number of subjects: 2819
Study 11464575 — intervention group
Group type: EXPERIMENTAL
Intervention: rhFSH alone (group F)
Number of subjects: 28
Study 11464575 — intervention group
Group type: COMPARATOR
Intervention: rhFSH + rhLH (group L)
Number of subjects: 28
Study 11464575 — intervention group
Group type: COMPARATOR
Intervention: Subgroup of group L (previous ART cycle with FSH only)
Number of subjects: 28
Study 11464575 — intervention group
Group type: COMPARATOR
Intervention: Conventional IVF cycles
Number of subjects: 28
Study 9677108 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed dressings (single‐ or 3‐layer composite foam, plastic mesh, hydrogel, or polymer film)
Number of subjects: 40
Study 9677108 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed dressings
Number of subjects: 40
Study 9677108 — intervention group
Group type: COMPARATOR
Intervention: Historical control (open dressings)
Number of subjects: 40
Study 8021637 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive psychodynamically and group-oriented program
Number of subjects: 165
Study 2684441 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 5923 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lorazepam (4 mg) plus IM meperidine (50 mg)
Number of subjects: 40
Study 5923 — intervention group
Group type: COMPARATOR
Intervention: IV placebo plus IM meperidine (50 mg)
Number of subjects: 40
Study 6987032 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenformin (50 mg)
Number of subjects: 0
Study 30575237 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) non-adherent behaviors (eg, confronting, persuading)
Number of subjects: 55
Study 30575237 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower patient self-efficacy for diabetes self-management
Number of subjects: 55
Study 30208866 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (5 mg)
Number of subjects: 12
Study 30208866 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (10 mg)
Number of subjects: 12
Study 30208866 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab (20 mg)
Number of subjects: 12
Study 26235468 — intervention group
Group type: EXPERIMENTAL
Intervention: miTLIF
Number of subjects: 50
Study 26235468 — intervention group
Group type: COMPARATOR
Intervention: coPLIF
Number of subjects: 50
Study 24810796 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine administration without prior oxygen
Number of subjects: 1957
Study 24810796 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine administration
Number of subjects: 1957
Study 21945866 — intervention group
Group type: EXPERIMENTAL
Intervention: lipid emulsion, LE (15 g Fabuless, containing 4.2g lipid, 0.2 MJ)+water
Number of subjects: 18
Study 21945866 — intervention group
Group type: COMPARATOR
Intervention: lipid control, LC (15 g non‐emulsified lipid/water, containing 4.2g lipid, 0.2 MJ)+water
Number of subjects: 18
Study 21945866 — intervention group
Group type: EXPERIMENTAL
Intervention: lipid emulsion+yoghurt, LE+Y (1.2 MJ)
Number of subjects: 18
Study 21945866 — intervention group
Group type: COMPARATOR
Intervention: lipid control+yoghurt, LC+Y (1.2 MJ)
Number of subjects: 18
Study 21945866 — intervention group
Group type: EXPERIMENTAL
Intervention: lipid emulsion+muffin, LE+M (1.2 MJ)
Number of subjects: 18
Study 21945866 — intervention group
Group type: COMPARATOR
Intervention: lipid control+muffin, LC+M (1.2 MJ)
Number of subjects: 18
Study 20414715 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular treatment in clinic settings
Number of subjects: 139
Study 20414715 — intervention group
Group type: COMPARATOR
Intervention: Modular treatment in community settings
Number of subjects: 139
Study 17630869 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 12
Study 17630869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15310747 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat, low-carbohydrate diet (HF/LC; 5% carbohydrate, 73% fat, and 22% protein)
Number of subjects: 0
Study 15310747 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat, low-carbohydrate diet (HF/LC)
Number of subjects: 0
Study 15310747 — intervention group
Group type: COMPARATOR
Intervention: Control diet (Con; 51% carbohydrate, 29% fat, and 20% protein)
Number of subjects: 0
Study 15310747 — intervention group
Group type: COMPARATOR
Intervention: Control diet (Con)
Number of subjects: 0
Study 11943438 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drug A
Number of subjects: 0
Study 11943438 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drug B
Number of subjects: 0
Study 12198781 — intervention group
Group type: EXPERIMENTAL
Intervention: Ehrenstein figures with varying contrast polarity and inducer spacing
Number of subjects: 0
Study 8602629 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF 250 microg/m2 subcutaneously every 12 hr after each course of DICEP until recovery of ANC of 1.5 x 10(9)/L
Number of subjects: 56
Study 8602629 — intervention group
Group type: COMPARATOR
Intervention: Placebo subcutaneously every 12 hr after each course of DICEP until recovery of ANC of 1.5 x 10(9)/L
Number of subjects: 56
Study 8602629 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF 250 microg/m2
Number of subjects: 56
Study 8602629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 1761663 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed administration of human chorionic gonadotrophin (HCG) by 24 hours in 96 patients.
Number of subjects: 143
Study 1761663 — intervention group
Group type: COMPARATOR
Intervention: Standard administration of human chorionic gonadotrophin (HCG) in 47 patients when the three largest follicles were >= 17 mm.
Number of subjects: 143
Study 7080505 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexoprenaline (beta‐2‐selective bronchodilator) in paediatric syrup form, dosage not specified, duration not specified
Number of subjects: 0
Study 7080505 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of obstruction using optimal body plethysmography
Number of subjects: 0
Study 7080505 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-flow curve analysis
Number of subjects: 0
Study 31823222 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 4 weeks (q4w)
Number of subjects: 251
Study 31823222 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 200 or 300 mg every 2 weeks (q2w)
Number of subjects: 251
Study 31823222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 251
Study 31062455 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerised cognitive training (8-week intervention period)
Number of subjects: 40
Study 31062455 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention group (control)
Number of subjects: 40
Study 30596775 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine (IIV)
Number of subjects: 155
Study 27374753 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective messages (N = 300)
Number of subjects: 1065
Study 27374753 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental messages (N = 238)
Number of subjects: 1065
Study 27374753 — intervention group
Group type: COMPARATOR
Intervention: No messages (N = 521)
Number of subjects: 1065
Study 25028506 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 4-hydroxytamoxifen gel (4-OHT) 4 mg/day
Number of subjects: 27
Study 25028506 — intervention group
Group type: COMPARATOR
Intervention: Oral tamoxifen (oral-T) 20 mg/day
Number of subjects: 27
Study 25028506 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 4-hydroxytamoxifen gel (4-OHT)
Number of subjects: 27
Study 25028506 — intervention group
Group type: COMPARATOR
Intervention: Oral tamoxifen (oral-T)
Number of subjects: 27
Study 22656335 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (10 mg orally daily)
Number of subjects: 700
Study 22656335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 700
Study 19695853 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity physical activity (Group B)
Number of subjects: 82
Study 19695853 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (Group C)
Number of subjects: 82
Study 19695853 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic+resistance exercise (Group D)
Number of subjects: 82
Study 19695853 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control (Group A)
Number of subjects: 82
Study 17378780 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 36
Study 17378780 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 36
Study 17378780 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 36
Study 16278360 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) of the left atrium during mitral valve surgery
Number of subjects: 97
Study 16278360 — intervention group
Group type: COMPARATOR
Intervention: Mitral valve surgery alone (control)
Number of subjects: 97
Study 12817747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) with cyclic estrogen and progestogen (norethisterone acetate) for 2 years
Number of subjects: 10
Study 9895220 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-dependent increases in oxidative damage markers
Number of subjects: 66
Study 9895220 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation between oxidative damage markers
Number of subjects: 66
Study 7718368 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 40
Study 7718368 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine
Number of subjects: 40
Study 7718368 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 40
Study 7718368 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine
Number of subjects: 40
Study 7718368 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine and bupivacaine
Number of subjects: 40
Study 2188408 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline via Turbohaler (powder)
Number of subjects: 140
Study 2188408 — intervention group
Group type: COMPARATOR
Intervention: Terbutaline via freon spray (aerosol)
Number of subjects: 140
Study 6104938 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 40
Study 6104938 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 40
Study 6104938 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine
Number of subjects: 40
Study 6104938 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 40
Study 12209433 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 20
Study 12209433 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 29477138 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed yoga practice
Number of subjects: 9
Study 29477138 — intervention group
Group type: COMPARATOR
Intervention: Cycling exercise at a self-selected intensity
Number of subjects: 9
Study 29477138 — intervention group
Group type: COMPARATOR
Intervention: Quiet rest
Number of subjects: 9
Study 27476110 — intervention group
Group type: EXPERIMENTAL
Intervention: Affect Regulation Treatment to Enhance Methamphetamine Intervention Success (ARTEMIS)
Number of subjects: 100
Study 27476110 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched control condition
Number of subjects: 100
Study 24169163 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 123
Study 24169163 — intervention group
Group type: COMPARATOR
Intervention: Early parenteral nutrition (EPN)
Number of subjects: 123
Study 22415569 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg rosiglitazone daily for 12 weeks
Number of subjects: 38
Study 22415569 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 12 weeks
Number of subjects: 38
Study 20109459 — intervention group
Group type: EXPERIMENTAL
Intervention: Imitated participants
Number of subjects: 0
Study 20109459 — intervention group
Group type: COMPARATOR
Intervention: Not imitated participants
Number of subjects: 0
Study 18604118 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 120
Study 18604118 — intervention group
Group type: COMPARATOR
Intervention: Intra-operative diagnosis
Number of subjects: 120
Study 18604118 — intervention group
Group type: COMPARATOR
Intervention: Histopathological diagnosis
Number of subjects: 120
Study 16027569 — intervention group
Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ)
Number of subjects: 638
Study 16027569 — intervention group
Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ) Physical subscale
Number of subjects: 638
Study 16027569 — intervention group
Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ) Emotional subscale
Number of subjects: 638
Study 16027569 — intervention group
Group type: EXPERIMENTAL
Intervention: Minnesota Living With Heart Failure Questionnaire (LHFQ) after deletion of problematic items
Number of subjects: 638
Study 11820462 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus hyperthermia (RT + HT)
Number of subjects: 114
Study 11820462 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 114
Study 10405677 — intervention group
Group type: EXPERIMENTAL
Intervention: Early postoperative enteral feeding protocol (jejunal feeding tube placed during surgery, initiated within 12 hours after surgery)
Number of subjects: 225
Study 10405677 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 225
Study 7577408 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH 0.05 mg/kg per day subcutaneously
Number of subjects: 125
Study 7577408 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 2289216 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (up to 40 mg daily)
Number of subjects: 159
Study 2289216 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release diltiazem (360 mg daily)
Number of subjects: 159
Study 2289216 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 159
Study 2289216 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release diltiazem
Number of subjects: 159
Study 6988933 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-lowering diet
Number of subjects: 100
Study 6988933 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 31722611 — intervention group
Group type: EXPERIMENTAL
Intervention: Online training resource
Number of subjects: 168
Study 31722611 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 168
Study 31122743 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-precaution group (NPG)
Number of subjects: 394
Study 31122743 — intervention group
Group type: COMPARATOR
Intervention: Precaution group (PG)
Number of subjects: 394
Study 31122743 — intervention group
Group type: EXPERIMENTAL
Intervention: NPG
Number of subjects: 394
Study 31122743 — intervention group
Group type: COMPARATOR
Intervention: PG
Number of subjects: 394
Study 27094749 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (local ambassadors, management support, environmental changes, a lecture and a workshop)
Number of subjects: 317
Study 27094749 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 317
Study 27094749 — intervention group
Group type: COMPARATOR
Intervention: Control (behave as usual)
Number of subjects: 317
Study 26038356 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate (6 mg intravenous or 50 mg oral)
Number of subjects: 3474
Study 26038356 — intervention group
Group type: COMPARATOR
Intervention: Ibandronate
Number of subjects: 3474
Study 24135743 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11
Study 24135743 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 11
Study 24135743 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 11
Study 21790680 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical beclomethasone dipropionate (BDP) 3mg enema during radiotherapy and 2x3mg suppositories for 4 weeks
Number of subjects: 120
Study 21790680 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical beclomethasone dipropionate (BDP)
Number of subjects: 120
Study 21790680 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 120
Study 20175432 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.4% CHO‐E solution
Number of subjects: 8
Study 20175432 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution (PLA)
Number of subjects: 8
Study 16465653 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 1353
Study 16465653 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept plus Methotrexate (MTX)
Number of subjects: 1353
Study 16465653 — intervention group
Group type: COMPARATOR
Intervention: Etanercept plus MTX
Number of subjects: 1353
Study 15024373 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (spray or swab)
Number of subjects: 34
Study 15024373 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 11743466 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based ENG system with caloric air stimulation
Number of subjects: 64
Study 9247517 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandbag placed over the site
Number of subjects: 400
Study 9247517 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure dressing constructed from surgical gauze and elastic tape
Number of subjects: 400
Study 9247517 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercially available compression device
Number of subjects: 400
Study 9247517 — intervention group
Group type: COMPARATOR
Intervention: No use of compressive dressing
Number of subjects: 400
Study 9247517 — intervention group
Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 400
Study 7973317 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal nocturnal sleep (2300 to 0700 hours)
Number of subjects: 7
Study 7973317 — intervention group
Group type: EXPERIMENTAL
Intervention: Shifted daytime sleep (0700 to 1500 hours)
Number of subjects: 7
Study 7973317 — intervention group
Group type: COMPARATOR
Intervention: Waking periods
Number of subjects: 7
Study 2499524 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg ibuprofen-lysinsalt
Number of subjects: 59
Study 2499524 — intervention group
Group type: COMPARATOR
Intervention: 50 mg diclofenac
Number of subjects: 59
Study 30947740 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidified high-flow oxygenation via nasal cannula at 60 L/min
Number of subjects: 0
Study 30947740 — intervention group
Group type: COMPARATOR
Intervention: Non-rebreather mask and standard nasal cannula at an oxygen flow rate of 15 L/min
Number of subjects: 0
Study 26400321 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-Guided Radiation Therapy (IGRT)
Number of subjects: 170
Study 26400321 — intervention group
Group type: COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy (IMRT)
Number of subjects: 170
Study 23902962 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit group (1.5 grapefruit/day for 6 weeks)
Number of subjects: 69
Study 23902962 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit group (1.5 grapefruit/day for 6 weeks) in adults with MetS
Number of subjects: 69
Study 23902962 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit group (1.5 grapefruit/day for 6 weeks) with high baseline F2-isoprostane concentrations
Number of subjects: 69
Study 23902962 — intervention group
Group type: COMPARATOR
Intervention: Control group (low bioactive diet devoid of citrus)
Number of subjects: 69
Study 21658221 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised eight‐week home‐based physical rehabilitation program with three physical trainer home visits and four follow‐up phone calls
Number of subjects: 195
Study 21658221 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 195
Study 21658221 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised eight‐week home‐based physical rehabilitation program
Number of subjects: 195
Study 18266537 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-aggression-focused behavioral couple therapy
Number of subjects: 134
Study 16365124 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate weight-bearing mobilisation after surgical repair
Number of subjects: 0
Study 16365124 — intervention group
Group type: COMPARATOR
Intervention: Immediate weight-bearing mobilisation after conservative treatment
Number of subjects: 0